Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetic nephropathy in type 2 diabetes prevention and patient management.

Literature DB >> 12707409

Diabetic nephropathy in type 2 diabetes prevention and patient management.

Gunter Wolf¹, Eberhard Ritz.

Abstract

Entities: Disease Species

Mesh：

Year: 2003 PMID： 12707409 DOI： 10.1097/01.asn.0000065639.19190.cf

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

Review 1. Renal autoregulation in health and disease.

Authors: Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal: Physiol Rev Date: 2015-04 Impact factor: 37.312

2. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis.

Authors: Shun-Min Yang; Shuk-Man Ka; Hua-Lin Wu; Yu-Chuan Yeh; Cheng-Hsiang Kuo; Kuo-Feng Hua; Guey-Yueh Shi; Yi-Jen Hung; Fone-Ching Hsiao; Sung-Sen Yang; Yi-Shing Shieh; Shih-Hua Lin; Chyou-Wei Wei; Jeng-Shin Lee; Chu-Yi Yang; Ann Chen
Journal: Diabetologia Date: 2013-11-30 Impact factor: 10.122

3. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.

Authors: S M Ka; Y C Yeh; X R Huang; T K Chao; Y J Hung; C P Yu; T J Lin; C C Wu; H Y Lan; A Chen
Journal: Diabetologia Date: 2011-11-16 Impact factor: 10.122

4. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.

Authors: Li Zhang; Ruizhao Li; Wei Shi; Xinling Liang; Shuangxin Liu; Zhiming Ye; Chunping Yu; Yuanhan Chen; Bin Zhang; Wenjian Wang; Yuxiong Lai; Jianchao Ma; Zhuo Li; Xiaofan Tan
Journal: Br J Pharmacol Date: 2013-09 Impact factor: 8.739

5. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.

Authors: John M Lachin; Giancarlo Viberti; Bernard Zinman; Steven M Haffner; R Paul Aftring; Gitanjali Paul; Barbara G Kravitz; William H Herman; Rury R Holman; Steven E Kahn
Journal: Clin J Am Soc Nephrol Date: 2011-03-31 Impact factor: 8.237

6. Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats.

Authors: Kai Pan; Xiaolei Shi; Kai Liu; Ju Wang; Yijun Chen
Journal: Drug Des Devel Ther Date: 2021-08-10 Impact factor: 4.162

Diabetic nephropathy in type 2 diabetes prevention and patient management.

Review 1. Renal autoregulation in health and disease.

2. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis.

3. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.

4. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.

5. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.

6. Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats.

7. [Diabetic nephropathy].

Review 8. The role of sulodexide in the treatment of diabetic nephropathy.

Review 9. Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment.

10. Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.